Medy-Tox Inc.

KOSDAQ:A086900 주식 보고서

시가총액: ₩1.0t

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Medy-Tox 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hyun-Ho Jung

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권19.7%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Mar 31
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Feb 27
Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Apr 02
Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Feb 09
A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Dec 18
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

CEO

Hyun-Ho Jung (62 yo)

no data

테뉴어

Mr. Hyun-Ho Jung serves as the Chief Executive Officer of Medy-Tox Inc. Mr. Hyun obtained Doctor of Science degree from Korea Advanced Institute of Science and Technology.